Quotient Sciences today announces the successful initiation of a clinical study evaluating a novel drug product developed ...
Sapu Nano and Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) today announced that Vuong Trieu, Chief Executive Officer, will present the Company’s Deciparticle™ nanomedicine platform at ...
Artificial intelligence is shifting formulation development from empirical trial-and-error to predictive, data-driven design ...
High-concentration formulations and patient centricity are challenges to the formulation of biosimilars, which already face patent protection barriers. Biosimilar formulation development requires ...
Clinical evaluation of several modified release once-daily formulations of danuglipron resulted in encouraging pharmacokinetic data for several candidates with one showing the most favorable profile ...
Quotient Sciences has announced the successful initiation of a clinical study evaluating a novel drug product developed using artificial intelligence (AI) - a landmark achievement highlighting the ...
The global formulation development outsourcing industry was estimated at $22.5 billion in 2021, and is anticipated to hit $51.9 billion by 2031, registering a CAGR of 9% from 2022 to 2031. The ...
Solubility is fundamental in successfully developing all classes of therapeutic biopolymers. Contact with stressors related to mechanical stirring or changes in buffer conditions may cause ...
As a contract research and development biotechnology firm, CD Formulation establishes new benchmarks for health care product development by delivering extensive product formulation services. From ...
Hyderabad, India: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage biopharmaceutical company ...
Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...